Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001193125-25-288556 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 2025-11-17 | SRPT | Rodino-Klapac Louise | Pres, R, D, Tech Ops | F - Tax | $18.42 | -4,582 | 224.0K | -2% | -$84.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | F | D | 4,582 | $18.42 | 224,030 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021. |